TELA Bio to Announce Second Quarter 2021 Financial Results
July 28 2021 - 6:00AM
TELA Bio, Inc. ("TELA"), a commercial-stage medical technology
company focused on designing, developing, and marketing innovative
tissue reinforcement materials to address unmet needs in soft
tissue reconstruction, today announced that the company will report
second quarter 2021 financial results on Wednesday, August 11,
2021. TELA Bio’s management will host a conference call and webcast
at 4:30 p.m. ET that day to discuss the financial results and
provide a corporate update.
Conference Call and Webcast DetailsThe
conference call can be accessed by dialing 855-548-1219 for
participants in the U.S. or Canada and 409-217-8881 for
international callers, using conference ID 9285257. A live and
archived webcast of the event can be accessed via the Events &
Presentations page of the investor section of TELA's website.
About TELA Bio, Inc.TELA Bio, Inc. (NASDAQ:
TELA) is a commercial-stage medical technology company focused on
designing, developing, and marketing innovative tissue
reinforcement materials to address unmet needs in soft tissue
reconstruction. The Company is committed to providing patients with
advanced, economically effective biologic material repair solutions
to minimize long-term exposure to permanent synthetic materials and
improve clinical outcomes. TELA Bio's OviTex® and OviTex PRS
Reinforced Tissue Matrix products are purposefully designed to
address the shortcomings of existing reinforcement materials in
hernia repair, abdominal wall reconstruction, and plastic and
reconstructive surgery. For more information, visit
www.telabio.com.
Investor ContactGreg
Chodaczek347-620-7010 ir@telabio.com
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From Apr 2024 to May 2024
TELA Bio (NASDAQ:TELA)
Historical Stock Chart
From May 2023 to May 2024